Organization
Guangdong Hengrui Pharmaceutical
15 clinical trials
Clinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Dose of SHR-4597 Inhalation in Healthy Subjects and Asthmatic PatientsStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetics of HRS-2261, the Effects of Food on the Pharmacokinetics of HRS-2261, and the Effects of HRS-2261 on CYP3A4 Metabolic Enzymes in Healthy Subjects After Single and Multiple Oral AdministrationStatus: Completed, Estimated PCD: 2022-10-25
Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single IV Infusion of SHR-1906 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-09-07
Clinical trial
A Phase II Seamless Design, Randomized, Double-blind, Placebo-controlled, Dose-exploration Study Evaluate the Efficacy and Safety of SHR-2010 Injection in Patients With Primary IgA NephropathyStatus: Recruiting, Estimated PCD: 2026-01-30
Clinical trial
Efficacy and Safety of Intravenous Infusion of SHR-1906 in Patients With Idiopathic Pulmonary Fibrosis: a Multicenter, Randomized, Double-blind, Parallel Placebo-controlled Phase II TrialStatus: Recruiting, Estimated PCD: 2024-05-31
Clinical trial
Safety, Tolerance, Pharmacokinetics and Pharmacodynamics Phase I Study of Increased Doses of Single and Multiple Atomized Inhalation of HRS-9821 Suspension for Inhalation in Healthy PeopleStatus: Recruiting, Estimated PCD: 2023-07-30
Clinical trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous/Subcutaneous Injection of SHR-2010 in Healthy Subjects: a Randomized, Double-blind, Dose-increasing, Placebo-controlled Phase I Clinical TrialStatus: Completed, Estimated PCD: 2023-03-10
Clinical trial
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study of Efficacy and Safety of HRS-2261 in Refractory Chronic CoughStatus: , Estimated PCD: 2024-03-30
Clinical trial
A Single-arm/Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2/3 Clinical Study to Evaluate the Efficacy and Safety of SHR-1703 for Patients With EGPAStatus: Recruiting, Estimated PCD: 2026-03-21
Clinical trial
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal PolypsStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase I Clinical Study on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2106 After a Single Intravenous or Subcutaneous Administration of SHR-2106 in Healthy SubjectsStatus: , Estimated PCD: 2024-06-15
Clinical trial
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2001 After a Single Subcutaneous Injection in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2023-12-20
Clinical trial
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 Following Single Intravenous Administration in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Multicenter, Single-group Phase II Clinical Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of Multiple Subcutaneous Injections of SHR-1703 in Eosinophilic Asthma PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-1819 Injection in Patients With Moderate to Severe Atopic DermatitisStatus: Not yet recruiting, Estimated PCD: 2025-04-30